open access immunology journals
TRANSCRIPT
Open AccessImmunology Journals
www.biomedcentral.com
www.biomedcentral.com/bmcimmunol
Impact Factor: 2.66
BMC Immunology is an open access, peer-reviewed journal that considers articles on molecular, cellular, tissue-level, organismal, functional, and developmental aspects of the immune system.
BMC Immunology is covered by PubMed, MEDLINE, BIOSIS, CAS, Scopus, EMBASE, Scopus, Google Scholar and Thomson Reuters (ISI).
www.biomedcentral.com/submit
www.aacijournal.com
Editor-in-Chief: Richard Warrington (Canada)
Allergy, Asthma & Clinical Immunology, the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI), is an open access journal that aims to further the understanding and treatment of allergic and immunologic disease.
By offering a high-visibility forum for new insights and discussions, the journal provides a platform for the dissemination of allergy and clinical immunology research and reviews amongst allergists, immunologists and other physicians, healthcare workers, medical students and the public world wide.
AACI is covered by PubMed, PubMed Central, CAS, PubMed Canada, Google Scholar, EMBASE and Scopus.
www.jneuroinflammation.com
Editors-in-Chief: Sue T Griffin (USA), Robert E Mrak (USA)
Impact Factor: 3.21
Journal of Neuroinflammation is an open access, peer-reviewed online journal that focuses on innate immunological responses of the central nervous system, involving microglia, astrocytes, cytokines, chemokines, and related molecular processes.
Journal of Neuroinflammation is covered by PubMed, PubMed Central, Thomson Reuters (ISI), CAS, BIOSIS, EMBASE, MEDLINE, CABI, Scopus and Google Scholar.
JOURNAL OF NEUROINFLAMMATION
http://arthritis-research.com
Editors-in-Chief: Peter E Lipsky (USA), Ravinder N Maini (UK)
Impact Factor: 4.49
Arthritis Research & Therapy is an international, peer-reviewed online journal publishing original research, reviews, commentaries and reports. The major focus of the journal is in mechanisms of, and translational laboratory and clinical research into localised and systemic immune-inflammatory and degenerative diseases of the musculoskeletal system. Phase I, II and III clinical trials are also published.
Arthritis Research & Therapy is covered by PubMed, PubMed Central, Google Scholar, MEDLINE, Scopus, Thomson Reuters (ISI), CABI, CAS and EMBASE.
www.clinicalmolecularallergy.com
Editors-in-Chief: David S Chi (USA), Guha Krishnaswamy (USA)
Unofficial Impact Factor: 3.06
Clinical and Molecular Allergy is an open access, peer-reviewed, online journal that publishes research on human allergic and immunodeficient disease (immune deficiency not related to HIV infection/AIDS). The scope of the journal encompasses all aspects of the clinical, genetic, molecular and inflammatory aspects of allergic-respiratory (Type 1 hypersensitivity) and non-AIDS immunodeficiency disorders. However, studies of allergic/hypersensitive aspects of HIV infection/AIDS or drug desensitization protocols in AIDS are acceptable.
Clinical and Molecular Allergy is covered by PubMed, PubMed Central, CAS, EMBASE, Scopus and Google Scholar.
CMA
www.biomedcentral.com/submit
www.immunityageing.com
Editor-in-Chief: Calogero Caruso (Italy)
Unofficial Impact Factor: 3.12
Immunity & Ageing is an open access, peer-reviewed, online journal that considers manuscripts on all aspects of ageing examined from an immunological point of view.
Immunity & Ageing is covered by PubMed, PubMed Central, CAS, Scopus, EMBASE and Google Scholar.
Immunome Research is an open access, peer-reviewed, online journal integrating cutting edge basic and clinical immunology research, genomics, proteomics, bioinformatics, and mathematical modelling with traditional laboratory research. The journal provides coverage of topics within the field of immunomics, including immunoinformatics, applications of genomics, proteomics, metabolomics, personalised medicine and diagnostics relevant to the immune system and its diseases. A journal of the International Immunomics Society.
Immunome Research is covered by PubMed, PubMed Central, CAS, Scopus, EMBASE and Google Scholar.
www.immunome-research.com
Editor-in-Chief: Nikolai Petrovsky (Australia)
www.journal-inflammation.com
Editors-in-Chief: Paul Kirkham (UK), Dennis Taub (USA)
Unofficial Impact Factor: 1.75
Journal of Inflammation is an open access, peer-reviewed online journal on all aspects of research into inflammation. The journal covers molecular, cellular, animal and clinical studies, and related aspects of pharmacology, such as anti-inflammatory drug development, trials and therapeutic developments. It also considers publication of negative findings.
Journal of Inflammation is affiliated with the British Inflammation Research Association (BIRAs).
Journal of Inflammation is covered by PubMed, PubMed Central, Thomson Reuters (ISI), BIOSIS, CAS, EMBASE, Scopus and Google Scholar
www.jibtherapies.com
Editor-in-Chief: Robert W Malone (USA)
Journal of Immune Based Therapies and Vaccines (JIBTV) is an open access, peer-reviewed, online journal dedicated to all aspects of therapeutic and prophylactic applications of immunology.
JIBTV is covered by PubMed, PubMed Central, CAS, EMBASE, Scopus and Google Scholar.
http://stemcellres.com
Editors-in-Chief: Rocky S Tuan (USA), Timothy O’Brien (Ireland)
Stem Cell Research & Therapy aims to be the major forum for translational research into stem cell therapies. An international peer-reviewed journal, it will publish open access research articles of outstanding quality. Stem Cell Research & Therapy will have a special emphasis on translational, laboratory, and clinical research into stem cells.
Stem Cell Research & Therapy is covered by Google Scholar.
To submit your next article to a journal published by BioMed Central go to
www.biomedcentral.com/submit
OPEN ACCESSAccess to the research published in our journals is free (not only on the journal’s website but also via PubMed Central, the National Institutes of Health’s electronic archive of full text articles, UK PubMed Central and other national archives), which means anyone with Internet access can read your research.
HIGH VISIBILITYResearch articles are freely available to the entire global scientific and medical communities. Average full-text downloads are 250 per article per month.
INCLUDED IN PUBMEDAll research articles published in BioMed Central’s journals are included in PubMed, so your work can be found and cited by researchers and clinicians around the world.
YOU RETAIN COPYRIGHT This means you can freely post your article on your personal or institutional homepage and e-mail it to friends and colleagues.
PUBLISHED QUICKLYOnline submission and peer review makes the whole process of publishing your research simple and efficient. Articles are published rapidly upon acceptance.
NO SPACE CONSTRAINTSPublishing online means unlimited space for figures, extensive data and video footage.
GET YOUR ARTICLE PROMOTED When appropriate, articles are promoted by e-mailing selected groups of researchers working in the same field or by informing the general and/or scientific press.
THE BENEFITS OF PUBLISHING INBIOMED CENTRAL’S JOURNALS:
Customer ServicesBioMed CentralCustomer Services DeptFloor 6236 Gray’s Inn RoadLondon, WC1X 8HL, UK
Tel: 0800 389 8136 (UK) Tel: +44 (0)20 3192 2009Fax: +44 (0)20 3192 2010Email: [email protected]
CONTACT INFORMATION
Global Health Gateway
www.biomedcentral.com/gateways/globalhealth